%0 Journal Article
%T 利妥昔单抗治疗系统性红斑狼疮合并慢性活动性EB病毒感染1例并文献复习<br>Rituximab in the Treatment of Systemic Lupus Erythematosus Complicated with Chronic Active Epstein-Barr Virus Infection: A Case Report and Literature Review
%A 田心怡
%A 温大蔚
%A 王茜
%A 郭庆敏
%A 孙明姝
%J Advances in Clinical Medicine
%P 1460-1466
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/acm.2024.1461935
%X 目的：探讨系统性红斑狼疮合并慢性活动性EB病毒感染的临床特征及诊治方法。方法：报道1例利妥昔单抗治疗系统性红斑狼疮合并慢性活动性EB病毒感染患者的临床资料，分析其临床特点及诊疗经过，复习国内外相关文献。结果：29岁女性患者，面部红斑9年余，1年内因发热多次住院，本次因反复发热半月伴咳嗽咽痛、头晕恶心、腹泻腹胀入院，结合病史查体及辅助检查，诊断为系统性红斑狼疮合并慢性活动性EB病毒感染，经利妥昔单抗500 mg q2w治疗后病情好转。结论：系统性红斑狼疮合并慢性活动性EB病毒感染病情复杂，应尽早明确诊断，本例应用利妥昔单抗有效，为临床治疗方案提供思路。<br />
Objective: To investigate the clinical features, diagnosis and treatment of systemic lupus erythematosus complicated with chronic active Epstein-Barr virus infection. Methods: The clinical data of a patient with systemic lupus erythematosus complicated with chronic active Epstein-Barr virus infection were reported, the clinical characteristics, diagnosis and treatment process were analyzed, and the relevant literature at home and abroad was reviewed. Results: A 29-year-old female patient with facial erythema for more than 9 years was hospitalized for fever for several times within 1 year, and was admitted to the hospital for recurrent fever for half a month with cough and sore throat, dizziness, nausea, diarrhea and abdominal distension, combined with medical history and physical examination and auxiliary examinations, she was diagnosed with systemic lupus erythematosus with chronic active Epstein-Barr virus infection, and her condition improved after treatment with rituximab 500 mg q2w.<i> </i>Conclusion: The condition of systemic lupus erythematosus complicated with chronic active Epstein-Barr virus infection is complex, and the diagnosis should be made as soon as possible. The application of rituximab in this case is effective and provides ideas for clinical treatment options.
%K 系统性红斑狼疮，慢性活动性EB病毒感染，利妥昔单抗<br>Systemic Lupus Erythematosus
%K Chronic Active Epstein-Barr Virus Infection
%K Rituximab
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=90540